| 1 |
Commentary concerning the "Measurement and correlation of the solubility of rivaroxaban (form I) in binary mixtures of ethyl acetate with tetrahydrofuran, N,N-dimethylformamide, and N,N-dimethylacetamide from T = (278.15 to 318.15) K"
Wu JX, Xu RJ, Zhao HK
Journal of Chemical Thermodynamics, 129, 138, 2019 |
| 2 |
Modified rivaroxaban microparticles for solid state properties improvement based on drug-protein/polymer supramolecular interactions
Chen N, Di PW, Ning SQ, Jiang WJ, Jing QF, Ren GB, Liu Y, Tang Y, Xu ZY, Liu GX, Ren FZ
Powder Technology, 344, 819, 2019 |
| 3 |
Remarks and further calculations on "Solubility measurement, model evaluation and thermodynamic analysis of rivaroxaban polymorphs in organic solvents"
Yang ZH, Shao DF, Zhou GQ, Hu Y, Li RR
Journal of Chemical Thermodynamics, 116, 134, 2018 |
| 4 |
Solubility measurement, model evaluation and thermodynamic analysis of rivaroxaban polymorphs in organic solvents
Zhai JH, Chen ZZ, Liu XJ, Zhang LJ, Lu J
Journal of Chemical Thermodynamics, 104, 218, 2017 |
| 5 |
Measurement and correlation of the solubility of rivaroxaban (form I) in binary mixtures of ethyl acetate with tetrahydrofuran, N,N-dimethylformamide, and N,N-dimethylacetamide from T = (278.15 to 318.15) K
Zhang MD, Fang ZX, Zhai JH, Mao SM, Zhang LJ, Rohani S, Lu J
Journal of Chemical Thermodynamics, 94, 1, 2016 |
| 6 |
Thermodynamic models for determination of the solubility of 4-(4-aminophenyl)-3-morpholinone in different pure solvents and (1,4-dioxane + ethyl acetate) binary mixtures with temperatures from (278.15 to 333.15) K
Yang WG, Fan SM, Guo QR, Hao JF, Li HJ, Yang SH, Zhao WD, Zhang J, Hu YH
Journal of Chemical Thermodynamics, 97, 214, 2016 |
